Casini Giamberto, Loiudice Pasquale, Pellegrini Marco, Sframeli Angela Tindara, Martinelli Paolo, Passani Andrea, Nardi Marco
Ophthalmology Unit, Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy.
Ophthalmology Unit, Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy.
Am J Ophthalmol. 2015 Dec;160(6):1185-1190.e1. doi: 10.1016/j.ajo.2015.08.022. Epub 2015 Aug 22.
To evaluate short-term changes in corneal endothelial cells after trabeculectomy, EX-PRESS device implantation, and Ahmed valve implantation for the treatment of primary open-angle glaucoma.
Prospective, interventional, comparative case series with contralateral eye control study.
We prospectively evaluated the changes in number, density, and shape of the corneal endothelium cells in 128 eyes of 64 patients divided into 3 groups depending on the treatment received. Corneal specular microscopy was performed with a noncontact specular microscope preoperatively and at 1 and 3 months after surgery. The changes at each time point were compared with those of the control group, which consisted of 32 contralateral glaucomatous eyes receiving antiglaucoma medications without any previous glaucoma surgery.
In the subjects who underwent trabeculectomy, corneal endothelial cell density (ECD) significantly decreased by 3.5% (P = .012, paired t test) at 1 month and 4.2% (P = .007) at 3 months after surgery, compared to the baseline values. In the Ahmed valve group ECD did not change at 1 month after surgery and had a significant 3.5% decrease at 3 months (P = .04). In the patients who underwent EX-PRESS implantation and in the control group ECD did not change either at 1 month or at 3 months after surgery (P > .05).
EX-PRESS shunt, compared to trabeculectomy and Ahmed valve, seems to be a safer procedure regarding the risk of endothelial cell loss. For this reason, it may be the treatment of choice in patients with significant low corneal ECD before surgery or other risk factors for corneal damage.
评估小梁切除术、EX-PRESS植入术和艾哈迈德瓣膜植入术治疗原发性开角型青光眼后角膜内皮细胞的短期变化。
前瞻性、干预性、对比病例系列研究,并设对侧眼对照。
我们前瞻性评估了64例患者128只眼中角膜内皮细胞数量、密度和形态的变化,这些患者根据接受的治疗分为3组。术前以及术后1个月和3个月使用非接触式角膜内皮显微镜进行角膜内皮显微镜检查。将每个时间点的变化与对照组进行比较,对照组由32只对侧青光眼眼组成,这些对侧眼接受抗青光眼药物治疗,之前未进行过任何青光眼手术。
与基线值相比,接受小梁切除术的患者术后1个月角膜内皮细胞密度(ECD)显著下降3.5%(P = .012,配对t检验),术后3个月下降4.2%(P = .007)。在艾哈迈德瓣膜组中,术后1个月ECD没有变化,术后3个月显著下降3.5%(P = .04)。接受EX-PRESS植入术的患者以及对照组术后1个月和3个月ECD均未发生变化(P > .05)。
与小梁切除术和艾哈迈德瓣膜相比,EX-PRESS分流术在内皮细胞丢失风险方面似乎是一种更安全的手术。因此,对于术前角膜ECD显著降低或存在其他角膜损伤风险因素的患者,它可能是首选治疗方法。